By: ICN Bureau
Last updated : February 23, 2026 5:36 pm
The move supports SIFL’s ambitious expansion strategy and aims to strengthen its position in next-generation, eco-friendly refrigerants with production slated for 2027
Stallion India Fluorochemicals Limited (SIFL), a leading integrated refrigerants and industrial gases company, has received approval from RIICO for allotment of land for its proposed Hydrofluoroolefin (HFO) manufacturing plant at the RIICO Industrial Area, Ukhalliya, District Bhilwara, Rajasthan.
Shazad Rustomji, Managing Director & CEO of Stallion India Fluorochemicals Limited, commented: “The approval for land allotment marks another important milestone in the execution of our Rajasthan expansion strategy. With the allotment of Plot No. SP2-9 measuring approximately 53,369 sq. mtrs, adjacent to our existing Plot SP3-10 measuring approximately 40,524 sq. mtrs and Plot SP3-11 measuring approximately 28,650 sq. mtrs, the Company now holds three adjoining plots totaling approximately 122,543 sq. mtrs. This enables us to develop a fully integrated manufacturing layout to support our expanding fluorochemicals operations.
The contiguous location of these plots will allow shared infrastructure, utilities, security, administration, and common factory management, creating strong operational synergies, improving efficiencies, and supporting cost optimization as we scale operations.
HFOs represent the next phase of low-global-warming-potential refrigerant technologies and will significantly strengthen our product portfolio and long-term competitiveness. Our expansion is being executed in a calibrated and phased manner, with the R-32 project targeted for commissioning by October 2026, followed by the proposed HFO manufacturing facility, for which we have outlined an investment of approximately Rs. 200 crore with start of work planned in 2027.
The Rajasthan project will also be eligible for incentives under RIPS-2024, including capexlinked benefits that, through a combination of subsidies such as SGST-linked incentives, capital and performance-linked support, interest subvention, and employment-linked benefits, can cumulatively extend up to 100% of the eligible fixed capital investment, significantly enhancing project viability and long-term returns, subject to approvals and eligibility conditions.
Backed by these strategic initiatives, we remain confident of achieving our targeted 30–35% revenue CAGR over the next three years, while building a strong domestic manufacturing base aligned with India’s vision of self-reliance in specialty chemicals and fluorochemicals, and delivering sustainable long-term value for all stakeholders.”